0000939767-21-000083.txt : 20210923
0000939767-21-000083.hdr.sgml : 20210923
20210923201609
ACCESSION NUMBER: 0000939767-21-000083
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210921
FILED AS OF DATE: 20210923
DATE AS OF CHANGE: 20210923
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Senner Christopher J.
CENTRAL INDEX KEY: 0001648367
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 211273718
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wf-form4_163244255527325.xml
FORM 4
X0306
4
2021-09-21
0
0000939767
EXELIXIS, INC.
EXEL
0001648367
Senner Christopher J.
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY
ALAMEDA
CA
94502
0
1
0
0
EVP and CFO
Common Stock
2021-09-21
4
M
0
90000
3.66
A
446591
D
Common Stock
2021-09-21
4
F
0
55057
20.33
D
391534
D
Common Stock
2723
I
By 401(k)
Option (right to buy)
3.66
2021-09-21
4
M
0
90000
0
D
2016-07-15
2022-07-14
Common Stock
90000.0
0
D
Includes 208,343 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units.
Represents a "net exercise" of an outstanding stock option. The Reporting Person received 34,943 shares of Common Stock on the net exercise of a stock option to purchase 90,000 shares of Common Stock. The Issuer withheld 55,057 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on September 21, 2021 of $20.33.
Represents shares of Common Stock under the Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of September 22, 2021.
The option, representing the right to purchase a total of 350,000 shares of Common Stock, became fully exercisable on July 15, 2019.
/s/ Jennifer Drimmer Rokovich, Attorney in Fact
2021-09-23